Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Enovis CorporationNYSE: ENOV

Free Cash Flow · Q1 FY2026 · quarter ended Apr 2026

Free cash flow dips below year-ago levels

Q1 FY2026 free cash flow of $28.85M (cash outflow) fell 35.7% year over year, behind the +192.1% change in trailing-twelve-month free cash flow.

Context

  • Free cash flow amounted to 0.9% of revenue in FY2025, down 2.3 pp from a year earlier.
  • Free cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -35.7% toward the trailing-twelve-month pace of +192.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
-$28.85M-189.4% QoQ
Last fiscal yearDec 2025
$19.92M+129.6% YoY
LTMApr 2026
$35.92M+192.1% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-35.7%——
1 year+129.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
19.92M USD
Year-over-year change
+129.6%
4-year CAGR
-47.0%

Free Cash Flow vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's LTM Apr 2026 free cash flow of $35.92M is the 12th largest of the 16 companies compared; the peer median is $159.99M.
  • Its year-over-year change of +192.1% is the highest of 16, against a peer median of +6.9%.
  • Free cash flow amounts to 1.6% of revenue for ENOV, versus a peer median of 13.1%.
ENOV Competitors Peer median
Free Cash Flow for ENOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IEXIDEX CorporationLTM Jun 2026$641.5M +9.3%+8.0%17.9%
ITTITT Inc.LTM Jul 2026$508.8M +4.4%+46.5%10.7%
MIDDThe Middleby CorporationLTM Jul 2026$495.68M -13.5%+28.5%13.9%
DCIDonaldson Company, Inc.LTM Jul 2026$426.3M +26.0%-0.0%11.0%
WTSWatts Water Technologies, Inc.LTM Jun 2026$349.4M +10.3%+22.1%13.1%
FELEFranklin Electric Co., Inc.LTM Sep 2026$193.49M -4.4%+47.9%8.5%
NPOEnPro Industries, Inc.LTM Jun 2026$163.4M +10.9%+17.7%13.4%
KAIKadant Inc.LTM Jul 2026$159.99M +6.6%+27.5%13.9%
EPACEnerpac Tool Group Corp.LTM Feb 2026$110.65M +55.8%+28.5%17.7%
GRCThe Gorman-Rupp CompanyLTM Jun 2026$108.4M +50.2%—15.4%
HLIOHelios Technologies, Inc.LTM Jul 2026$106.9M +6.9%+8.6%12.0%
ENOVEnovis CorporationLTM Apr 2026$35.92M +192.1%—1.6%
LXFRLuxfer Holdings PLCLTM Mar 2026$16.02M -62.1%+51.1%4.3%
OFLXOmega Flex, Inc.LTM Mar 2026$14.25M -19.1%+2.4%14.5%
HURCHurco Companies, Inc.LTM Apr 2026$7.95M +20.7%—4.4%
GHMGraham CorporationLTM Mar 2026$121K -102.3%—0.0%
Peer median (excluding ENOV) $159.99M+6.9%+24.8%13.1%

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income76.28M(11.76M)(33.26M)(824.82M)(1.18B)
Depreciation & Amortization262.92M219.71M217.1M284.8M294.38M
Deferred Income Tax(22.19M)6.32M(27.41M)(10.02M)(2.23M)
Stock-Based Compensation35.35M38.96M34.07M29.66M32.92M
Change in Working Capital(17.1M)(220.49M)(27.27M)(13.93M)15.47M
Accounts Receivables(110.99M)(45.19M)(16.32M)(57.05M)(10.75M)
Inventory(129.97M)(118.79M)(24.74M)39.07M(11.98M)
Accounts Payables178.47M(11.84M)(6.64M)13.98M(1.14M)
Other Working Capital45.38M(44.67M)20.42M(9.93M)39.34M
Other Non-Cash Items20.84M(88.59M)(28.24M)647.81M1.06B
Operating Cash Flow356.1M(55.86M)134.99M113.5M217.29M
Capital Expenditures(104.24M)(105.45M)(122.22M)(180.71M)(197.38M)
Acquisitions (Net)(223.27M)(73.68M)(152.82M)(769.91M)16.4M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities7.03M2.75M32.57M(4.85M)1.6M
Investing Cash Flow(320.48M)(176.39M)(242.47M)(955.47M)(179.37M)
Debt Repayment(150.41M)(1.59B)217.2M859.23M(43.6M)
Common Stock Issued745.18M5.81M1.78M1.87M1.32M
Common Stock Repurchased000(4.77M)0
Dividends Paid00000
Other Financing Activities(9.87M)1.12B(91.17M)(9.51M)(10.12M)
Financing Cash Flow584.91M(465.13M)127.8M846.82M(52.4M)
Effect of Forex Changes(2.23M)2.3M219K(1.52M)2.7M
Net Change in Cash618.3M(695.08M)20.54M3.34M(11.78M)
Free Cash Flow251.86M(161.31M)12.77M(67.21M)19.92M

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.